Microneedles with Tunable Dissolution Rate
Source abstract
Abstract
Dissolvable microneedle (MN) patches have been widely investigated for transdermal drug delivery. The dissolution rate of MN controls the status of drug release from the MN, which in turn determines drug absorption through skin. However, no systematic approaches have been reported to tune the dissolution profile of dissolvable MN matrices. This is the first study to show polyvinylpyrrolidone (PVP)-based dissolvable MN patches with varying dissolution profiles when PVP is copolymerized with cellulose materials. The MN patches were fabricated through thermal curing and photolithography in tandem. The various grades of pharmaceutical cellulose, such as hydroxypropyl methylcellulose and methyl cellulose, have been investigated as dissolution modifier incorporated in the MN patches. The resultant MN patches had dissolution profiles ranging from 45 min to 48 h. The dissolution rates varied with the grades of cellulose materials. Besides dissolution examination, the MN patches were characterized for their mechanical strength, moisture absorption, and skin penetration efficiency. All of the MN patches were able to penetrate the human skin in vitro. Overall, the PVP MN patches have great potential for skin applications as drug carriers with tunable dissolution profiles.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Dermatology and Skin Diseases · Contact Dermatitis and Allergies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmacy, National University of Singapore, Singapore 117543, Singapore
School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales 2006, Australia
Department of Mechanical Engineering, Sogang University, Seoul 04107, Korea
References (27)
Show source-provided references
1. 10.4155/tde-2018-001210.4155/tde-2018-0012 ↗
2. 10.1016/j.jconrel.2019.12.03510.1016/j.jconrel.2019.12.035 ↗
3. 10.2147/DDDT.S4440110.2147/DDDT.S44401 ↗
4. 10.1016/j.ejps.2017.11.03110.1016/j.ejps.2017.11.031 ↗
5. 10.1038/s41598-018-30290-310.1038/s41598-018-30290-3 ↗
6. 10.1007/s10544-016-0113-810.1007/s10544-016-0113-8 ↗
7. 10.1016/j.jconrel.2017.06.01610.1016/j.jconrel.2017.06.016 ↗
8. 10.1186/s40413-016-0122-310.1186/s40413-016-0122-3 ↗
9. 10.1002/adma.20070120510.1002/adma.200701205 ↗
10. 10.1021/acs.nanolett.5b0503010.1021/acs.nanolett.5b05030 ↗
11. 10.1016/j.jconrel.2019.09.02210.1016/j.jconrel.2019.09.022 ↗
12. 10.1016/j.ijpharm.2019.11899210.1016/j.ijpharm.2019.118992 ↗
13. 10.1016/j.ijpharm.2014.05.04210.1016/j.ijpharm.2014.05.042 ↗
14. 10.1002/jps.2456310.1002/jps.24563 ↗
15. 10.1007/s13346-015-0245-z10.1007/s13346-015-0245-z ↗
16. 10.1002/bmc.342610.1002/bmc.3426 ↗
17. Dow Chemistry of methocel cellulose ethers: a technical review; https://msdssearch.dow.com/PublishedLiteratureDOWCOM/dh_08e5/0901b803808e5f58.pdf?filepath=dowwolff/pdfs/noreg/198-02289.pdf&fromPage=GetDoc (accessed 12/07/2020).
18. 10.1039/C6RA19746A10.1039/C6RA19746A ↗
19. 10.1208/s12249-008-9159-010.1208/s12249-008-9159-0 ↗
20. 10.3390/polym612296110.3390/polym6122961 ↗
21. 10.1016/j.actbio.2013.04.04510.1016/j.actbio.2013.04.045 ↗
22. 10.1016/j.ijpharm.2017.02.01110.1016/j.ijpharm.2017.02.011 ↗
23. 10.3390/pharmaceutics704039710.3390/pharmaceutics7040397 ↗
24. 10.3390/pharmaceutics1107030810.3390/pharmaceutics11070308 ↗
25. 10.1016/j.ijpharm.2015.01.01910.1016/j.ijpharm.2015.01.019 ↗
26. 10.1248/cpb.42.212110.1248/cpb.42.2121 ↗
27. 10.1371/journal.ppat.100604510.1371/journal.ppat.1006045 ↗